NIH Funding Policy Frequently Criticized by Republicans for "Lack of Oversight," is Based on HHS Framework Created by Trump Administration
What's odd is that shares of two independent vaccine makers would gradually recover, and eventually peak on Febuary 25th, while shares of a third vaccine maker would fall 5.5% during after-market hours, only to make headline news the morning of Febuary 26th.